These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5168671

  • 1. Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides.
    Baker BR, Doll MH.
    J Med Chem; 1971 Sep; 14(9):793-9. PubMed ID: 5168671
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible enzyme inhibitors. CLVI. Proteolytic enzymes. XII. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jul; 12(4):677-80. PubMed ID: 5815693
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible enzyme inhibitors. CLXI. Proteolytic enzymes. 13. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides. II.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Sep; 12(5):902-5. PubMed ID: 5812209
    [No Abstract] [Full Text] [Related]

  • 4. Irreversible enzyme inhibitors. Inhibitors of guinea pig complement derived by quaternization of substituted pyridines with benzyl halides.
    Doll MH, Baker BR.
    J Med Chem; 1976 Sep; 19(9):1079-88. PubMed ID: 978671
    [Abstract] [Full Text] [Related]

  • 5. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
    Baker BR, Cory M.
    J Med Chem; 1971 Sep; 14(9):805-8. PubMed ID: 5140007
    [No Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of 3-(3,4-dichlorophenoxyacetamido)-N-(3-chloro-2-fluorosulphonylbenzyl) pyridinium bromide on bovine complement.
    Pang AS, Schmidt DE, Aston WP.
    Life Sci; 1973 Aug 16; 13(4):351-62. PubMed ID: 4796227
    [No Abstract] [Full Text] [Related]

  • 7. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar 16; 11(2):233-41. PubMed ID: 5654208
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships in immunochemistry. III. Inhibition of complement by benzyl pyridinium ions.
    Yoshimoto M, Hansch C, Jow PY.
    Chem Pharm Bull (Tokyo); 1975 Feb 16; 23(2):437-44. PubMed ID: 1157202
    [No Abstract] [Full Text] [Related]

  • 9. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jan 16; 12(1):118-22. PubMed ID: 5763006
    [No Abstract] [Full Text] [Related]

  • 10. Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
    Rubbini G, Buades-Martín AB, Kimatrai-Salvador M, Entrena A, Gallo-Mezo MÁ, Ríos-Marco P, Marco C, Mattiuzzo E, Bortolozzi R, Mariotto E, Greco FA, Macchiarulo A, Carrasco-Jiménez MP, Viola G, López-Cara LC.
    Future Med Chem; 2018 Aug 01; 10(15):1769-1786. PubMed ID: 30043647
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.
    Arab S, Sadat-Ebrahimi SE, Mohammadi-Khanaposhtani M, Moradi A, Nadri H, Mahdavi M, Moghimi S, Asadi M, Firoozpour L, Pirali-Hamedani M, Shafiee A, Foroumadi A.
    Arch Pharm (Weinheim); 2015 Sep 01; 348(9):643-9. PubMed ID: 26192069
    [Abstract] [Full Text] [Related]

  • 12. Pyridinium- and quinolinium-2-dithioacetic acid zwitterions: antiradiation and anticancer activities.
    Foye WO, Lee YJ, Shah KA, Kauffman JM.
    J Pharm Sci; 1978 Jul 01; 67(7):962-4. PubMed ID: 660516
    [Abstract] [Full Text] [Related]

  • 13. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar 01; 11(2):241-5. PubMed ID: 5654209
    [No Abstract] [Full Text] [Related]

  • 14. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
    Baker BR, Cory M.
    J Med Chem; 1969 Nov 01; 12(6):1049-52. PubMed ID: 5389146
    [No Abstract] [Full Text] [Related]

  • 15. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group.
    Baker BR, Ashton WT.
    J Med Chem; 1972 Sep 01; 15(9):945-7. PubMed ID: 5051014
    [No Abstract] [Full Text] [Related]

  • 16. Effects of protease inhibitors on protein breakdown in Escherichia coli.
    Prouty WF, Goldberg AL.
    J Biol Chem; 1972 May 25; 247(10):3341-52. PubMed ID: 4554917
    [No Abstract] [Full Text] [Related]

  • 17. Effects of protease inhibitors on protein breakdown and enzyme induction in starving Escherichia coli.
    Goldberg AL.
    Nat New Biol; 1971 Nov 10; 234(45):51-2. PubMed ID: 4942896
    [No Abstract] [Full Text] [Related]

  • 18. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V, McSorley T, See Too WC, Konrad M, Campos JM.
    ChemMedChem; 2012 Apr 10; 7(4):663-9. PubMed ID: 22278967
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of omega-amino and omego-guanidino acid esters on the first component of human complement.
    Muramatu M, Shiraishi S, Fujii S.
    Biochim Biophys Acta; 1972 Nov 28; 285(1):224-34. PubMed ID: 4675901
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.